ATAI · AtaiBeckley Inc.
$7.42
+0.06 (+0.82%)
At close · Aug 20
Market Cap
$2.75B
Shares
370.86M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$7.42
Open$7.38
Day$7.35–7.45
52W close$3.35–7.42
Avg vol 30d15.9M
Short int19.9M · 5.4% float · 1.0d
Short vol16%
Last earningsMar 6, 2026
DataJun 2021–Aug 2026
Filing10-Q · Aug 11
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 11, 2026
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Neutral
Momentum
Very Strong
Sentiment
Bullish
Fundamentals
Weak
Quant / Vol
High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+65%
above
Price vs 50-day avg
+24%
above
RSI (14)
76
overbought
MACD trend
Negative
52-week position
100%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+3%
trailing
6-month return
+104%
trailing
YTD return
+81%
this year
Relative strength
+93%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $6 › 200d $5 — 50d above 200d
Institutional flow
Accumulating
+32% holders QoQ · +85 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
5.35% of float · ▼ -47.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
238 holders — 13F breadth
Squeeze score
52
elevated · 0–100
Fundamentals
Revenue growth
+1228%
Y/Y
EPS growth
−213%
Y/Y
Free cash flow
$-103.6M
Balance sheet
$50.1M
net debt
Quant / Vol
risk profile
Volatility
80%
annualized · 1-yr
Max drawdown
−48%
past year
ATR
1.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+65%
Bullish
Price vs 50-day avg
+24%
Bullish
RSI (14)
76
Bearish
MACD trend
Negative
Bearish
52-week position
100%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $6 › 200d $5 — 50d above 200d
Institutional flow
Accumulating
+32% holders QoQ · +85 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
5.35% of float · ▼ -47.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
238 holders — 13F breadth
Price context
position in its 52-week range
Range low $3
Now $7 · 100%
Range high $7
vs 200-day avg +65%
vs 50-day avg +24%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ATAI
this stock
AtaiBeckley Inc.
|
$2.75B | +81.4% | +1227.6% | — | 5.4% |
|
ONC
BeOne Medicines Ltd.
|
$557.05B | +21.5% | +22179.2% | 856.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$136.93B | +19.2% | +46.2% | 31.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$86.39B | +7.1% | +20.8% | 20.8 | 3.3% |
|
MRNA
Moderna, Inc.
|
$69.62B | +352.1% | +4.3% | — | 12.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ATAI | +2.3% | +3.5% | +104.4% | +3.3% | +81.4% |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | +4.3% | +0.2% | +93.2% | +1.3% | +69.6% |
Key facts
CIK
2081043
CUSIP
04650F101
13F (30d)
221 filings
221 filers
Visit website
Investor relations